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Introduction
MGC-0109 (ammonium tetrathiomolybdate) is a long-
acting sulphide donor that reversibly inhibits mitochon-
drial respiration. We previously found that MGC-0109
reduced oxidative stress and doubled 6-hour survival in a
severe haemorrhage/reperfusion rat model (1). Here we
explore its utility in an organ-specific ischaemia/reperfu-
sion injury.
Objectives
To assess the efficacy of MGC-0109 in a rat model of
myocardial ischaemia/reperfusion injury.
Methods
Ventilated, anaesthetized rats (4/group) were instrumented
with vascular lines for drug/fluid administration. Following
thoracotomy, the left anterior descending (LAD) coronary
artery was ligated for 30 min. Just prior to reperfusion,
animals received i.v. MGC-0109 (10 mg/kg bolus) or
n-saline. MGC-0109-treated animals received a further
2.5 mg/kg infusion over 15 min. Control animals received
equivalent volumes of n-saline. Animals were monitored
for a further 4 h. The LAD was then re-ligated and per-
fused with Evans Blue dye to determine the area at risk.
Hearts were then excised, sliced in 1mm sections distal to
the LAD ligature, and incubated with (red) tetrazolium
chloride (taken up by non-infarcted tissue). Statistics:
Non-parametric t test.
Results
MGC-0109 given at reperfusion reduced infarct size by
40%. Due to the current small sample size, these values
are not statistically significant.
Conclusions
MGC-0109 given just prior to reperfusion shows protec-
tive utility in myocardial ischaemia/reperfusion injury.
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